Intra-Cellular Therapies
ITCI
#1339
Rank
NZ$23.69 B
Marketcap
$223.03
Share price
-0.19%
Change (1 day)
82.00%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.60

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.81. In 2022 the company made an earnings per share (EPS) of -$4.75 an increase over its 2021 EPS that were of -$6.11.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.60-45.19%
2022-$4.75-22.29%
2021-$6.118.02%
2020-$5.6520.9%
2019-$4.68-5.63%
2018-$4.9633.96%
2017-$3.70-21.19%
2016-$4.69-7.56%
2015-$5.08174.53%
2014-$1.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.44-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.45 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.73 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA